This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hershey, A. E. Articles by Vail, D. M. Search for Related Content PubMed PubMed Citation Articles by Hershey, A. E. Articles by Vail, D. M.

Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

Department of Medical Sciences [A. E. H., I. D. K., D. M. V.] and Surgical Sciences [L. J. F., C. A. B.], School of Veterinary Medicine, and The Comprehensive Cancer Center [D. M. V.], University of Wisconsin-Madison, Madison, Wisconsin 53706, and Battelle Memorial Institute, Columbus, Ohio 43201 [M. S., M. E. P., A. R. I.]

This study represents part of an effort to determine the safety and efficacy of inhaled antineoplastic drugs, using pet dogs with spontaneously arising primary and metastatic lung cancers (including sarcoma, carcinoma, and malignant melanoma) as a model. Dogs received new formulations of either paclitaxel (PTX) or doxorubicin (DOX) by the inhalation route every 2 weeks using a specially designed aerosol device. Response was assessed radiographically using the indices of tumor nodule number and volume measurement of discrete pulmonary nodules. Dogs experiencing progressive disease after two consecutive treatments were crossed over to receive the alternate compound. In 24 dogs, 6 (25%) responses were noted including 5 partial responses (PR) and 1 complete response. These include 4 (22.2%) of 18 responses to DOX and 2 (13.3%) of 15 responses to PTX. Responses were noted with osteosarcoma (including three dogs with metastatic osteosarcoma that had failed prior systemic chemotherapy), liposarcoma, hemangiosarcoma, and undifferentiated sarcoma. One dog with mammary carcinoma experienced a 47% reduction in volume after PTX inhalation, just shy of PR criteria. One dog with liposarcoma is experiencing a long-term (>12 months) stabilization of disease on PTX. To date, no systemic toxicities have been observed with either PTX or DOX inhalations. Local (pulmonary) toxicity was not observed with PTX; however, changes consistent with pneumonitis/fibrosis were observed in some dogs receiving DOX. Only one of these dogs showed clinical signs, which were responsive to steroid and antitussive therapy. These data represent "proof of principle" for the avoidance of systemic toxicity while delivering efficacious local drug levels by the inhalation route.

This article has been cited by other articles:

				B. P.H. Wittgen, P. W.A. Kunst, K. van der Born, A. W. van Wijk, W. Perkins, F. G. Pilkiewicz, R. Perez-Soler, S. Nicholson, G. J. Peters, and P. E. Postmus Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung Clin. Cancer Res., April 15, 2007; 13(8): 2414 - 2421. [Abstract] [Full Text] [PDF]

				G. A. Otterson, M. A. Villalona-Calero, S. Sharma, M. G. Kris, A. Imondi, M. Gerber, D. A. White, M. J. Ratain, J. H. Schiller, A. Sandler, et al. Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs Clin. Cancer Res., February 15, 2007; 13(4): 1246 - 1252. [Abstract] [Full Text] [PDF]

				F. Gagnadoux, A. L. Pape, E. Lemarie, S. Lerondel, I. Valo, V. Leblond, J-L. Racineux, and T. Urban Aerosol delivery of chemotherapy in an orthotopic model of lung cancer Eur. Respir. J., October 1, 2005; 26(4): 657 - 661. [Abstract] [Full Text] [PDF]

				D. M. Vail and D. H. Thamm Cytotoxic Chemotherapy: New Players, New Tactics J. Am. Anim. Hosp. Assoc., July 1, 2005; 41(4): 209 - 214. [Abstract] [Full Text] [PDF]

				S. Sharma, D. White, A. R. Imondi, M. E. Placke, D. M. Vail, and M. G. Kris Development of Inhalational Agents for Oncologic Use J. Clin. Oncol., March 15, 2001; 19(6): 1839 - 1847. [Abstract] [Full Text] [PDF]